APA (7th ed.) Citation

Jensvoll, H., Blix, K., Brækkan, S. K., & Hansen, J. (2014). Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study. PLoS ONE, 9(3), e92011.

Chicago Style (17th ed.) Citation

Jensvoll, Hilde, Kristine Blix, Sigrid Kufaas Brækkan, and John-Bjarne Hansen. "Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study." PLoS ONE 9, no. 3 (2014): e92011.

MLA (9th ed.) Citation

Jensvoll, Hilde, et al. "Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study." PLoS ONE, vol. 9, no. 3, 2014, p. e92011.